Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma.

about

Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma.

Item

http://www.wikidata.org/entity/Q37406901

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma.

@en

Testin

@nl

type

Item

label

Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma.

@en

Testin

@nl

prefLabel

Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma.

@en

Testin

@nl

P1476

Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma

@en

P2093

Arimantas Tamasauskas

http://www.w3.org/2001/XMLSchema#string

Arunas Kazlauskas

http://www.w3.org/2001/XMLSchema#string

Daina Skiriute

http://www.w3.org/2001/XMLSchema#string

Kestutis Skauminas

http://www.w3.org/2001/XMLSchema#string

Paulina Vaitkiene

http://www.w3.org/2001/XMLSchema#string

P2860

The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein

The 2007 WHO classification of tumours of the central nervous system

A simple salting out procedure for extracting DNA from human nucleated cells

Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2

Survival and low-grade glioma: the emergence of genetic information

Downregulation of RUNX3 and TES by hypermethylation in glioblastoma.

Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene.

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.

Clinical ramifications of "genomic staging" of low-grade gliomas.

P304

3305-3311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.5077

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giedrius Steponaitis

Indre Valiulyte

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27899997

http://www.w3.org/2001/XMLSchema#string

P932

5103931

http://www.w3.org/2001/XMLSchema#string